BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 22503803)

  • 1. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.
    Moeller HB; Rittig S; Fenton RA
    Endocr Rev; 2013 Apr; 34(2):278-301. PubMed ID: 23360744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrogenic diabetes insipidus].
    Evrard A; Lefebvre J; Vantyghem M
    Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic diabetes insipidus.
    Bichet DG
    Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic Diabetes Insipidus.
    Kavanagh C; Uy NS
    Pediatr Clin North Am; 2019 Feb; 66(1):227-234. PubMed ID: 30454745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrogenic diabetes insipidus].
    Ishikawa S
    Nihon Rinsho; 1996 Mar; 54(3):819-24. PubMed ID: 8904243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
    Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
    Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of nephrogenic diabetes insipidus.
    Hureaux M; Vargas-Poussou R
    Mol Cell Endocrinol; 2023 Jan; 560():111825. PubMed ID: 36460218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary nephrogenic diabetes insipidus].
    Morin D; Ala Y; Dumas R
    Arch Pediatr; 1995 Jun; 2(6):560-7. PubMed ID: 7640759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
    Boson WL; Della Manna T; Damiani D; Miranda DM; Gadelha MR; Liberman B; Correa H; Romano-Silva MA; Friedman E; Silva FF; Ribeiro PA; De Marco L
    Genet Test; 2006; 10(3):157-62. PubMed ID: 17020465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
    García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
    Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS; Cogdell DE; Valadez V
    Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.